• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肝素和双氢麦角胺使用相关的可逆性血管痉挛。

Reversible vasospasm in association with the use of heparin and dihydroergotamine.

作者信息

Bachner E J, Konsens R M, Priem L, King T, Froimson A I

机构信息

Department of Orthopaedic Surgery, Mt. Sinai Medical Center, Cleveland, Ohio.

出版信息

Clin Orthop Relat Res. 1992 Oct(283):261-4.

PMID:1395256
Abstract

A case of reversible vasospasm is reported in a 54-year-old man with a closed bimalleolar ankle fracture. On admission the patient had normal distal pulses and laboratory studies. He was a heavy smoker who continued to smoke in the hospital. Deep venous thrombosis (DVT) prophylaxis included dihydroergotamine and heparin (DHE-H). In the early postoperative period, marked spasm of all three arteries developed on the operative side. Smoking privileges and DHE-H were discontinued. The vasospasm resolved after intraarterial nitroglycerin. This case suggests an infrequent but potentially limb-threatening complication of DHE-H.

摘要

本文报道了一例54岁闭合性双踝骨折男性患者发生可逆性血管痉挛的病例。入院时患者远端脉搏及实验室检查均正常。他是一名重度吸烟者,住院期间仍继续吸烟。深部静脉血栓形成(DVT)预防措施包括双氢麦角胺和肝素(DHE-H)。术后早期,术侧所有三条动脉均出现明显痉挛。吸烟特权及DHE-H停用。动脉内注射硝酸甘油后血管痉挛缓解。该病例提示DHE-H存在一种罕见但可能危及肢体的并发症。

相似文献

1
Reversible vasospasm in association with the use of heparin and dihydroergotamine.与肝素和双氢麦角胺使用相关的可逆性血管痉挛。
Clin Orthop Relat Res. 1992 Oct(283):261-4.
2
[Arterial vasospasm as a complication of the prevention of thromboembolism with heparin-dihydroergotamine and its treatment].
Zentralbl Chir. 1986;111(21):1354-7.
3
[Arterial spasm caused by administration of DHE-heparin in a tibial fracture].
Aktuelle Traumatol. 1984 Aug;14(4):142-5.
4
United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.美国关于双氢麦角胺与肝素预防深静脉血栓形成的试验。
Am J Surg. 1985 Oct 8;150(4A):25-32.
5
[Angiospasm and dihydroergotamine--dangers in thromboprevention].
Zentralbl Chir. 1985;110(18):1115-21.
6
Bilateral upper extremity ischemia after administration of dihydroergotamine-heparin for prophylaxis of deep venous thrombosis.
J Vasc Surg. 1988 Oct;8(4):410-4. doi: 10.1067/mva.1988.avs0080410.
7
Severe vasospastic reactions (ergotism) during prophylactic administration of heparin-dihydroergotamine.
Vasa. 1987;16(4):370-2.
8
Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.低分子量肝素联合双氢麦角胺预防术后深静脉血栓形成
Br J Surg. 1986 Sep;73(9):697-700. doi: 10.1002/bjs.1800730906.
9
Dihydroergotamine-heparin to prevent postoperative deep vein thrombosis.
Med Lett Drugs Ther. 1985 May 24;27(688):45-6.
10
Lower-limb vasospasm and renal failure during postoperative thromboprophylaxis. Case report.
Eur J Surg. 1991 Apr;157(4):289-92.